|
HS Code |
497853 |
| Cas Number | 446-06-6 |
| Iupac Name | 2-oxo-2-phenylacetaldehyde |
| Molecular Formula | C8H6O2 |
| Molecular Weight | 134.13 g/mol |
| Appearance | Yellow to orange crystalline solid |
| Melting Point | 50-54 °C |
| Boiling Point | 143-145 °C at 2 mmHg |
| Solubility | Slightly soluble in water; soluble in organic solvents like ethanol and ether |
| Density | 1.20 g/cm³ |
| Smiles | C1=CC=C(C=C1)C(=O)C=O |
| Synonyms | Benzoylformaldehyde, Benzoylglyoxal, Phenylglyoxal monohydrate |
| Refractive Index | 1.625 |
As an accredited Phenylglyoxal factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Phenylglyoxal is packaged in a 25g amber glass bottle with a secure screw cap, displaying hazard labels and product information. |
| Shipping | Phenylglyoxal is shipped as a hazardous chemical, typically in tightly sealed containers to prevent leaks and contamination. It should be protected from moisture and stored at room temperature. Appropriate labeling and documentation, including safety data sheets, are required. Transport must comply with regulations for toxic, corrosive, or reactive substances. |
| Storage | Phenylglyoxal should be stored in a cool, dry, well-ventilated area away from incompatible materials such as strong oxidizers, acids, and bases. Keep the container tightly closed and protected from light and moisture. Store in a flammable liquid storage cabinet if possible. Properly label all containers and avoid sources of ignition, as Phenylglyoxal is flammable and may be harmful if inhaled or ingested. |
Applications of Phenylglyoxal in Industrial ManufacturingPhenylglyoxal is a specialized reactive intermediate favored by industrial formulators for its unique reactivity with nucleophilic groups. As a direct manufacturer, we focus on high-purity supply to sectors where precise formulation and strict regulatory compliance are essential. Below are detailed application scenarios demonstrating our product's integration across critical downstream industries. 1. Protein Modification for Diagnostic ReagentsDiagnostic reagent formulators employ phenylglyoxal to selectively derivatize arginine residues in proteins, crucial for site-directed binding and antibody development. The controlled reactivity allows for fine modification of enzyme or antibody structure without compromising functional activity, facilitating the manufacture of high-specificity immunoassay components utilized in clinical diagnostics kits. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Crosslinker for Synthetic Polymer HydrogelsPhenylglyoxal serves as a selective crosslinking agent for hydrogel-based matrices requiring tailored porosity and mechanical strength. Its bifunctional aldehyde group reacts with amines and guanidino groups in polymer chains, creating durable networks used in chromatographic supports and biomedical hydrogel patches. The precision in crosslink density impacts product consistency and application performance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Pharmaceutical Intermediate for Active Pharmaceutical Ingredient (API) SynthesisIn pharmaceutical manufacturing, phenylglyoxal acts as a key intermediate for synthesizing various heterocyclic core structures, including imidazoles and substituted phenyl derivatives that form the backbone of several anti-infective and cardiovascular APIs. Precision in its use impacts yield and impurity profile, subject to stringent regulatory and in-process controls throughout GMP-compliant facilities. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Selective Derivatization Agent in Analytical ChemistryAnalytical laboratories use phenylglyoxal to derivatize specific functional groups—primarily guanidines in amino acid and peptide analysis—to enhance detection sensitivity and selectivity in HPLC and fluorometric assays. Controlled reaction parameters and rigid standard operating procedures ensure consistent results in both research and pharmaceutical QC environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Fine Chemical Synthesis for Agrochemical IntermediatesSpecialty agrochemical producers utilize phenylglyoxal for constructing certain benzyl and heterocyclic intermediates required in synthesis pathways for plant growth regulators and select fungicides. Its aldehyde function introduces structural moieties under controlled reaction conditions, supporting scalable agrochemical manufacturing while adhering to industry traceability measures. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Phenylglyoxal prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Phenylglyoxal has become an essential staple in our production portfolio over the decades. Anyone with hands-on time in a synthetic chemistry lab knows the rare frustration of finding a reliable, high-purity source of aromatic glyoxal. Early on, we learned most suppliers simply repackaged what they sourced from distant, anonymous plants. Building our own facility and controlling each synthesis step solved more problems than expected. From precursor distillation and oxidation, to proprietary purification methods, we committed to making sure labs downstream never have to fight batch inconsistencies or hidden impurities.
Our team handles phenylglyoxal at a technical grade above 99.0% purity, confirmed by GC analysis from each lot. The yellow oil remains stable during reasonable storage, provided you keep the container sealed and away from light and airborne moisture. Our standard model comes in volumes ranging from 500g to 200kg, with tightly measured water content and low residual benzaldehyde. Researchers in organic synthesis and pharmaceutical development—especially those focused on arginine modification in protein chemistry—have relied on this consistency for dependable results. We designed our solvent packaging based on real lessons from shipping and daily lab handling, focusing on leak-proof seals and hazard reduction.
Many years ago, several customers described yield problems and unexpected byproducts while using common phenylglyoxal. Our technical team asked for samples and traced the culprit to impurities just above 0.5%. In a reaction forming sensitive Schiff bases or dihydroquinoxalines, even trace water or benzaldehyde ruins reproducibility and can stop downstream reactions. This type of challenge forced us to improve both our equipment and our protocols. We upgraded filtration, reinforced glove box handling, and invested in better drying agents. Each improvement saved time for everyone involved. We now check for not just GC signal ratios but also color and odor changes, both of which hint at developing peroxides or polymerization that can sneak up during transit.
Other phenylglyoxal grades sold on the open market sometimes drop purity below 98%, and rarely have supporting QC data. We found that unfiltered, poorly stored batches form sediments or, in worst cases, embrace side reactions that generate colored polymers. This leads to excessive background in sensitive analytics and introduces unknowns that make scale-up nearly impossible. For academic and R&D teams, such headaches cost both time and grant money. As the manufacturer, we build our entire process around tight quality control, instead of simply ticking off standard requirements. Every technician here works with a direct feedback loop from our end-users, not just a form dropped in a database.
Customers use our material in a range of areas. Biochemists count on phenylglyoxal for site-directed modification of proteins. The compound reacts specifically with arginine side chains, letting researchers map out protein structures or block specific sites to study enzymatic functions. This method only succeeds if contaminants and side products are held below detection limits. We have seen labs run weeks-long campaigns where a single low-grade batch derailed the entire process. To avoid this, our production line follows strict validation for protein-activity impact, not just chemical purity.
Pharmaceutical research relies on phenylglyoxal for synthesizing intermediates in quinoxaline derivatives and related structure-activity probes. Peptide mapping, protein cross-linking, and other bioconjugation protocols all need consistent reactivity. Some chemical processes require multiple kilograms per month, so it is not enough to meet purity at gram scale. Bulk manufacturing brings its own problems: oxygen ingress, container compatibility, and thermal sensitivity all threaten quality if left unchecked. We responded by customizing both drum linings and shipment methods—sometimes double-walled flasks, sometimes nitrogen-flushed vessels—tailored for each volume to keep degradation under control.
While traders and distributors move pallet-loads of generic phenylglyoxal, they rarely know exactly what is inside each drum. Our team took a different approach. We documented the exact synthetic route, optimized every cleanup step, and archived retention samples from each batch. Reproducibility matters even more than single measures of purity. In peptide chemistry, inconsistent reagent lots can introduce invisible side reactions that only reveal problems weeks later when biological activity drops or when mass spec fingerprints drift. Chemists who depend on phenylglyoxal cannot afford to hunt for sources every production cycle.
Others in the industry ask why bother keeping water content so low or why over-engineer your headspace protection. Our direct experience says narrow control over batch parameters strongly impacts downstream synthesis. For example, a 0.2% jump in water content may seem like minutiae, but for arginine derivatization or aldehyde-amine coupling, it can mean a 10% drop in yield or puzzling false negatives in analytical readouts. Sometimes a problem looks like a failed enzyme, when the reagent quality was the real issue. Every year, we encounter requests for urgent replacement after a researcher chases unexpected results, only to trace them to generic phenylglyoxal lots that skimped on controls.
We have tested dozens of third-party batches on request from clients stymied by synthesis failures. A common story: a researcher relies on catalog supplies, but notices a strange color shift or struggling purification. After running NMR and GC-MS, we often spot minor benzaldehyde peaks, excess hydrates, or unexpected oligomers—sometimes up to 3% of the content. At this point, not only does the user waste time and solvent, but the likelihood of side reactions climbs steeply. Our own experience troubleshooting such issues confirmed the need for deep molecular analysis of every batch, not just a surface-level COA. Some cheaper sources skip this, assuming end users will simply tolerate the variability.
In another case, a manufacturer attempted process scale-up but ran into filter clogging and exothermic spikes beyond the lab scale. Poorly controlled phenylglyoxal batches, often those stored in soft plastics or exposed to moisture, generated low-level polymeric material that slowly precipitated out. This choked flow reactors and led to expensive downtime. Such avoidable setbacks underline the industry gap between trader-handled and producer-controlled phenylglyoxal. Direct intervention—upgrading to glass-lined shipping containers, monitoring each transit step, and adding real-time temperature logging—helped us eliminate the issue in our logistics pipeline.
Writing GMP protocols often feels like paperwork, but hands-on production reveals why these checks matter. Contaminant monitoring, glassware integrity, and staff training all impact the end product. We built a continuous audit cycle: every employee has a clear line of feedback from QC, and there is no wall between production and customer service. When a new client asks about our batch-lot cycle, we don’t send a brochure; one of our chemists talks through recent data and invites them to review retention samples. This open-door practice keeps accountability visible and makes improvement a shared responsibility.
In response to customer requests, we adapted packaging—from single-use ampoules for research labs, to bulk containers sealed under argon for large-scale synthesis. In every scale, strict batch tracing matches each drum to a line in our QC database and, when the need arises, we provide access to sample chromatograms and impurity profiles, not just standard purity numbers. Our production line skips superficial ‘meets standard’ claims and shows actual user impact. Here, every bottle filled carries proof of direct input from working chemists and process engineers.
In practice, chemical manufacturers face hard choices. Cutting corners in washing, drying, or stock rotation increases throughput in theory. The cost comes weeks later, when a subtle impurity poisons a step in a multi-stage synthesis. We regularly measure not just water content but free aldehyde, residual precursors, and trace side products that seldom make it into competitor certifications. Empirical evidence backs our approach: long-term customers see higher synthetic yields and less time wasted troubleshooting. We make this visible with voluntarily supplied retention data and will send proof to partners—no need for special requests or premium charges.
We maintain a single, tightly specified model of phenylglyoxal precisely because dilution or alternate grades breed confusion and compound risk for technical clients. Avoiding multiple forms eliminates misunderstandings and cross-contamination in storage or reaction planning. Chemical manufacturing governance insists on repetitive validation, but we exceed standard thresholds, guided by direct field feedback, not abstract policy. This level of care grew out of the failures we ourselves faced in complex synthesis runs, where unspotted impurities torpedoed weeks of work.
Shipping phenylglyoxal brings its own risks—especially with the compound’s reactivity toward humidity and ambient oxygen. Those who handle commodity chemicals sometimes store or transfer material without airtight seals, oblivious to the slow formation of hydrates or peroxides. Each missed detail compounds. Our plant adopted dedicated climate-controlled storage and direct-loading systems. Before any batch leaves for a customer, our packing team documents oxygen and humidity exposure. Customers notice: complaints about off-odors, sediment, or color drift have disappeared since we switched to this workflow.
We keep routine channels open with those using phenylglyoxal downstream. Years ago, one pharmaceutical project needed unbroken cold chain due to an unexpected stability challenge during a pilot run. Because our teams handle both manufacturing and shipping, we found a way to pre-cool shipper containers, add real-time data loggers, and track every shipment. No third-party bottleneck or unclear oversight. The new process worked, and the partner hit full-scale production weeks ahead of schedule.
The work doesn’t end at shipping. Our technical support follows customer development and trouble-shooting calls closely. If an R&D group faces aberrant results, we can provide matched reference material for analytical comparison, or even troubleshoot their handling technique. Some users ask for customized volumes, and we keep flexible batch scheduling specifically because a real lab’s needs don’t always match a rigid wholesaler’s cycle. Our site rarely sits idle, and production scheduling adapts to feedback from the chemists who actually use phenylglyoxal in synthesis.
Our continuing research into synthesis optimization drives slow but steady improvements. By investing profits from this niche chemical back into process upgrades—higher-purity raw materials, advanced drying methods, and better shipping—we strengthen the system that our commercial and academic clients rely on. This kind of steady improvement doesn’t show up quickly in the market, but any researcher stuck with failed reactions knows its value firsthand. This all stems from the belief that chemical manufacturing must focus on end-use integrity, not just cost or scale.
We have seen customers return year after year because of the transparency and hands-on control we offer. Traders rarely understand batch variability beyond labels and paperwork. Companies who handle the full cycle from raw material distillation, to synthesis, packaging, and shipping, build expertise directly from their own headaches and victories. We took our time building every step because every missed impurity or mishandled shipment hit our own bottom line. Over time, that pain built lasting trust and spurred continuing improvement.
If your project demands precise protein labeling, synthesis of targeted pharmaceuticals, or any protocol sensitive to aldehyde quality, real partnerships with manufacturers matter. It grants uninterrupted access to technical staff, rapid troubleshooting, unambiguous lot tracing, and honest feedback about risks and limitations. Instead of generic assurances, you get answers formed from practical experience—and accountability when something goes wrong. As our partners discovered, many issues that looked like technical or engineering mysteries came down to underlying reagent quality, and once addressed, led to breakthrough results.
Working in chemical production shows, day by day, that end-use success depends on details too fine for a trader’s ledger. Each chromatogram, each impurity profile, and each packaging choice carries real consequences for chemists in the field. Take water control, for example. It is easy to set a nominal threshold, harder to maintain it through real storage and transit cycles. Over the years, we strengthened control by switching to new drying agents, glass packaging, and real-time container monitoring. These steps require both investment and stubborn progress, not just sales talk.
Every synthesis run—large or small—relies on predictable reactivity from phenylglyoxal. Our team understands the pressure users feel when scaling from test tube to pilot plant, so our process never stops at just meeting the basics. Real-world problems—batch-to-batch drift, process bottlenecks, or analytical surprises—are all too familiar to us from personal experience. We invite collaboration at every stage. That means not only delivering product, but also honest input about risks, handling tips, and process adaptations. The difference comes through in yield, consistency, and time saved on troubleshooting.
Across decades of production, every improvement in phenylglyoxal quality, packing, and support came straight from troubleshooting and learning inside the plant and out in our customers’ labs. Anyone who relies on this compound for high-precision synthesis quickly recognizes the gap between true manufacturer-grade material and what floats through distributor networks. Chemical manufacturing, in reality, punishes shortcuts and rewards solid, step-by-step progress that never sidesteps the hard details—purity, handling, customer feedback, and total accountability. Our phenylglyoxal remains the benchmark not because we claim it, but because chemistry, and the scientists who run it, demand nothing less.